Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thess

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Head & Neck|April 9, 2005
Trifunctional bispecific antibody-induced tumor cell lysis of squamous cell carcinomas of the upper aerodigestive tractSilke S Gronau, Michael Schmitt, Bernard Thess, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1986
[Erythema annulare centrifugum and Hashimoto's thyroiditis]F Thess, J L Rigon, J F Cuny, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 9, 2015
Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large AnimalsAndreas Thess, Stefanie Grund, Barbara L Mui, et al.
The Journal of Gene Medicine|January 21, 2012
Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effectMariola Fotin-Mleczek, Kai Zanzinger, Regina Heidenreich, et al.
Vaccines|August 26, 2022
Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody ResponsesNicole Roth, Jacob Schön, Donata Hoffmann, et al.
International Journal of Oncology|September 18, 2004
Opsonization with a trifunctional bispecific (alphaCD3 x alphaEpCAM) antibody results in efficient lysis in vitro and in vivo of EpCAM positive tumor cells by cytotoxic T lymphocytesM Schmitt, A Schmitt, P Reinhardt, et al.
BMC Cancer|June 26, 2009
Production and characterisation of monoclonal antibodies against RAI3 and its expression in human breast cancerHannah Jörissen, Nuran Bektas, Edgar Dahl, et al.
Human Vaccines & Immunotherapeutics|August 8, 2013
A novel, disruptive vaccination technology: self-adjuvanted RNActive(®) vaccinesKarl-Josef Kallen, Regina Heidenreich, Margit Schnee, et al.
Nature Biotechnology|November 20, 2012
Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infectionBenjamin Petsch, Margit Schnee, Annette B Vogel, et al.
Nutrients|March 13, 2025
Developing and Testing a User-Focused, Web GIS-Based Food Asset Map for an Under-Resourced Community in Northeastern ConnecticutXiran Chen, Manije Darooghegi Mofrad, Sydney Clements, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Head & Neck|April 9, 2005
Trifunctional bispecific antibody-induced tumor cell lysis of squamous cell carcinomas of the upper aerodigestive tractSilke S Gronau, Michael Schmitt, Bernard Thess, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1986
[Erythema annulare centrifugum and Hashimoto's thyroiditis]F Thess, J L Rigon, J F Cuny, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 9, 2015
Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large AnimalsAndreas Thess, Stefanie Grund, Barbara L Mui, et al.
The Journal of Gene Medicine|January 21, 2012
Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effectMariola Fotin-Mleczek, Kai Zanzinger, Regina Heidenreich, et al.
Vaccines|August 26, 2022
Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody ResponsesNicole Roth, Jacob Schön, Donata Hoffmann, et al.
International Journal of Oncology|September 18, 2004
Opsonization with a trifunctional bispecific (alphaCD3 x alphaEpCAM) antibody results in efficient lysis in vitro and in vivo of EpCAM positive tumor cells by cytotoxic T lymphocytesM Schmitt, A Schmitt, P Reinhardt, et al.
BMC Cancer|June 26, 2009
Production and characterisation of monoclonal antibodies against RAI3 and its expression in human breast cancerHannah Jörissen, Nuran Bektas, Edgar Dahl, et al.
Human Vaccines & Immunotherapeutics|August 8, 2013
A novel, disruptive vaccination technology: self-adjuvanted RNActive(®) vaccinesKarl-Josef Kallen, Regina Heidenreich, Margit Schnee, et al.
Nature Biotechnology|November 20, 2012
Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infectionBenjamin Petsch, Margit Schnee, Annette B Vogel, et al.
Nutrients|March 13, 2025
Developing and Testing a User-Focused, Web GIS-Based Food Asset Map for an Under-Resourced Community in Northeastern ConnecticutXiran Chen, Manije Darooghegi Mofrad, Sydney Clements, et al.
Pageof 6